
Cellevolve develops novel cell therapies to address unmet medical needs through advanced biomanufacturing and strategic partnerships.


Cellevolve combines cutting-edge biomanufacturing with strategic partnerships to transform cell therapies from lab to clinic.

Cellevolve's advanced manufacturing platforms enable scalable, reproducible production of cell therapies with consistent quality and reduced cost.

From discovery through commercialization, Cellevolve streamlines the path to market with integrated expertise and established regulatory partnerships.

Cellevolve collaborates with leading academic institutions to access cutting-edge research, validate approaches, and strengthen clinical evidence.

Cellevolve operates with GMP standards and regulatory expertise built in, reducing timelines and risk as therapies advance toward patient access.

Cellevolve prioritizes therapies targeting conditions with limited treatment options, maximizing clinical impact and patient benefit.

Cellevolve supports pharma and biotech partners at every stage, from technology transfer and manufacturing scale-up to market launch and beyond.
Cellevolve's cell therapies are advancing patient outcomes through partnerships with leading healthcare institutions and research organizations.
Cellevolve's manufacturing platform enabled us to move our therapy from the lab to clinical trials faster than we thought possible. Their expertise in biomanufacturing was invaluable.

Dr. James Martinez
Chief Scientific Officer, Academic Medical Center
Working with Cellevolve transformed how we approach cell therapy commercialization. Their collaborative approach and technical depth gave us confidence in our pathway to market.

Sarah Chen
VP of Business Development, Biotech Company
The team at Cellevolve understood our unmet medical needs and designed a therapy strategy tailored to our patient population. Their commitment to patient outcomes is genuine.

Dr. Michael Thompson
Medical Director, Hospital Network
Cellevolve's advanced biomanufacturing platforms reduced our production timelines by months. They're serious about accelerating patient access to cell therapies.

Dr. Aisha Patel
Director of Manufacturing, Regenerative Medicine Company
From discovery to commercialization, Cellevolve provided the expertise and infrastructure we needed. Their San Francisco team is truly dedicated to advancing cell therapy innovation.

Dr. Robert Kim
Founder, Cell Therapy Start-up
Cellevolve's collaborative model with academic partners accelerates research impact. They bridge the gap between discovery and real-world application better than anyone we've worked with.

Dr. Elena Rodriguez
Professor of Cell Biology, Research University
Cellevolve accelerates novel treatments through advanced biomanufacturing and strategic partnerships. Our progress reflects our commitment to solving unmet medical needs.
5+
Active cell therapy programs
Cellevolve develops multiple therapeutic candidates addressing serious unmet medical needs.
15+
Academic and industry partners
Collaborations with leading institutions accelerate our path from discovery to commercialization.
3
Manufacturing platforms
Advanced biomanufacturing capabilities enable scalable production of cell therapies.
San Francisco
Based in innovation hub
Operating from San Francisco, California, Cellevolve connects research with real-world patient impact.
Cellevolve offers tiered service packages designed to support partners at every stage, from early research through commercial manufacturing.
Custom
project-basedFoundational cell therapy development with advanced biomanufacturing platform access and technical support.
Features:
Custom
contract-basedEnd-to-end support scaling cell therapies from development into clinical and commercial production.
Features:
Custom
volume-basedDedicated biomanufacturing capacity for proven cell therapy candidates with full GMP compliance.
Features:
Custom
collaborativeAccelerated discovery and validation programs for academic institutions driving cell therapy innovation.
Features:
Find answers about Cellevolve's services, partnerships, and cell therapy development process.
Cellevolve develops novel cell therapies designed to address unmet medical needs. Our advanced biomanufacturing platforms enable us to create cutting-edge treatments. We work with academic and industry partners to move therapies from discovery through commercialization.
We combine proprietary biomanufacturing technology with strategic partnerships to shorten time-to-market. Our platform supports research and development, scale-up, and manufacturing. This integrated approach helps therapies reach patients faster.
Cellevolve collaborates with leading academic institutions and industry partners to strengthen therapy development. These partnerships bring expertise, resources, and validation to advance our programs. We're open to new partnerships that align with our mission.
We provide research support, manufacturing expertise, commercialization guidance, and technology licensing. Our team helps partners navigate cell therapy development from early stage through market launch. Contact us to discuss how we can support your program.
Cellevolve is headquartered in San Francisco, California. Our location in the Bay Area connects us with leading research institutions, biotech talent, and industry partners driving innovation in cell therapy.
Reach out to our team to discuss partnership opportunities, investment, or collaboration. We're available to answer questions about our therapies, services, and vision for advancing patient outcomes in cell therapy.
Contact our team to discuss how Cellevolve can advance your cell therapy program.

Connect with our team to explore partnerships, licensing opportunities, or investment in the next generation of cell therapies.